pachyonychia congenita | ClinicalTrials HQ

View definition

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Epidermal Growth Factor Receptor Inhibition for Keratinopathies	Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ichthyosiform Erythroderma, Congenital, Infant, Newborn, Diseases, Keratoderma, Palmoplantar, Skin Abnormalities, Skin and Connective Tissue Diseases, ectodermal dysplasia syndrome, epidermolytic ichthyosis, hereditary disease, hereditary skin disorder, ichthyosis, keratosis, nail disorder, pachyonychia congenita, skin disorder	Not yet recruiting	Phase 1 / Phase 2	2026-08-03		NCT06545695
A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita	Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, ectodermal dysplasia syndrome, hereditary disease, hereditary skin disorder, nail disorder, pachyonychia congenita, skin disorder	Recruiting	Phase 3	2022-12-09		NCT05643872
International Pachyonychia Congenita Research Registry	Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cysts, Neurologic Manifestations, Pain, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Abnormalities, Skin and Connective Tissue Diseases, ectodermal dysplasia syndrome, hereditary disease, hereditary skin disorder, leukoplakia, nail disorder, neoplasm, pachyonychia congenita, precancerous condition, skin disorder	Recruiting	Not stated	2018-11-21		NCT02321423